Association between obesity and neurodevelopmental delay risk in children under five years: A study from Tumbes, Peru

Miriam Arredondo-Nontol1,2, Rodolfo Arredondo-Nontol1,2, Narcisa Reto1,3

  • 1Hospital Carlos Alberto Cortez Jimenez Essalud Tumbes, Tumbes, Peru.

Plos One
|March 6, 2026
PubMed

Insights

Childhood obesity increases neurodevelopmental delay risk in children under five. A new nomogram aids early risk identification in primary care settings.

Area of Science:

  • Pediatric Public Health
  • Developmental Pediatrics
  • Global Health

Background:

  • Childhood obesity presents a growing public health challenge in low- and middle-income countries.
  • Early neurodevelopmental vulnerability may be linked to childhood obesity, but data from Latin America is scarce.

Purpose of the Study:

  • To assess the association between childhood obesity and neurodevelopmental delay risk in Peruvian children under five.
  • To create a predictive nomogram for estimating this risk in primary care.

Main Methods:

  • An analytical cross-sectional study involved 431 children aged 0-59 months in Tumbes, Peru.
  • Neurodevelopment was evaluated using the Evaluación del Desarrollo Infantil (EDI); obesity was defined by WHO standards.
  • Ordinal logistic regression identified risk factors, and a nomogram was developed and validated.

Main Results:

  • Childhood obesity was independently associated with a 2.73 times higher odds of neurodevelopmental delay risk.
  • Male sex and older age increased risk; caregiver knowledge of feeding was protective.
  • Anemia and physical activity were not significant independent factors in the final model.

Conclusions:

  • Childhood obesity is a significant risk factor for neurodevelopmental delay in young children.
  • A nomogram utilizing routine data can assist in early risk stratification in primary care.
  • External validation is recommended for wider clinical application.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.